Western blotting and mRNA expression analyses of tumor tissues from patients with HCC have suggested that the expression of MARCH5 gradually decreases with increasing tumor grades (G1–G4), and Kaplan-Meier analysis has shown that high MARCH5 expression is associated with prolonged survival in patients with HCC (64). The gene discussed is MARCHF5; the disease is hepatocellular carcinoma.